Carol Giltner Gallagher's Net Worth
$9.94 Million
Who is Carol Giltner Gallagher?
Carol Giltner Gallagher has an estimated net worth of $9.94 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Atara Biotherapeutics, Inc., ANAPTYSBIO INC, Certara, Inc., Frazier Lifesciences Acquisition Corp, Metacrine, Inc., Millendo Therapeutics, Inc., Annexon, Inc., Mirati Therapeutics, Inc., PMV Pharmaceuticals, Inc., ANADYS PHARMACEUTICALS INC, and CANCERVAX CORP.
SEC CIK
Carol Giltner Gallagher's CIK is 0001329959
Past Insider Trading and Trends
2017 was Carol Giltner Gallagher's most active year for acquiring shares with 14 total transactions. Carol Giltner Gallagher's most active month to acquire stocks was the month of May. 2015 was Carol Giltner Gallagher's most active year for disposing of shares, totalling 18 transactions. Carol Giltner Gallagher's most active month to dispose stocks was the month of July. 2023 saw Carol Giltner Gallagher paying a total of $468,184.47 for 455,147 shares, this is the most they've acquired in one year. In 2018 Carol Giltner Gallagher cashed out on 28,240 shares for a total of $957,114.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27 - Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.28% | 150K |
—
|
—
| 629.61K |
Mar 31
| |||
Form 4
| +142.54% | 270K |
$0.25 | $68,214.48 | 459.42K |
Nov 13 - Nov 14
| |||
Form 4
| +43.05% | 57K |
—
|
—
| 189.42K |
May 31
| |||
Form 4
| +18.32% | 20.5K |
—
|
—
| 132.42K |
Jun 23
| |||
Form 4
| +10.91% | 11K |
—
|
—
| 111.82K |
Jun 8
| |||
Form 4
| +8.62% | 8K |
—
|
—
| 100.82K |
Jun 16
| |||
Form 4
| +4.50% | 4K |
—
|
—
| 92.82K |
Jun 27
| |||
Form 4
| -19.40% | -21.37K |
$36.38 | -$777,586.12 | 88.82K |
Nov 7
| |||
Form 4
| -2.22% | -2.50K |
$44.78 | -$111,944.00 | 110.19K |
Scheduled
|
Jun 18
| ||
Form 4
| +1.35% | 1.5K |
—
|
—
| 112.69K |
Jun 14
| |||
Form 4
| +0.25% | 272 |
$46.06 | -$12,574.38 | 111.19K |
Scheduled
|
May 15 - May 16
| ||
Form 4
| +1.08% | 1.18K |
$46.50 | -$55,009.50 | 110.92K |
Scheduled
|
Feb 15 - Feb 16
| ||
Form 4
| +1.09% | 1.18K |
$14.20 | -$16,812.80 | 109.74K |
Scheduled
|
Nov 15 - Nov 16
| ||
Form 4
| +1.10% | 1.18K |
$14.30 | -$16,931.20 | 108.56K |
Scheduled
|
Aug 15 - Aug 16
| ||
Form 4
| +3.87% | 4K |
$13.15 | -$13,150.00 | 107.37K |
Scheduled
|
Jun 8 - Jun 9
| ||
Form 4
| +1.16% | 1.18K |
$15.25 | -$18,056.00 | 103.37K |
Scheduled
|
May 15 - May 16
| ||
Form 4
| +1.17% | 1.18K |
$16.10 | -$19,046.30 | 102.19K |
Scheduled
|
Feb 15 - Feb 16
| ||
Form 4
| +2.02% | 2K |
—
|
—
| 101.01K |
Jan 3
| |||
Form 4
| +1.21% | 1.18K |
$19.35 | -$22,910.40 | 99.01K |
Scheduled
|
Nov 15 - Nov 16
| ||
Form 4
| +2.48% | 2.37K |
—
|
—
| 97.83K |
Aug 15
| |||
Form 4
| +1.25% | 1.18K |
$15.96 | -$18,896.64 | 95.46K |
Scheduled
|
May 16 - May 18
| ||
Form 4
| +1.27% | 1.18K |
$16.30 | -$19,282.90 | 94.28K |
Scheduled
|
Feb 16 - Feb 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +1.29% | 1.18K |
$31.10 | -$36,822.40 | 93.1K |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
| -16.09% | -17.62K |
$42.34 | -$746,090.26 | 91.92K |
Scheduled
|
Aug 20 - Aug 24
| ||
Form 4
| +74.82% | 46.88K |
$48.78 | -$567,708.82 | 109.54K |
Scheduled
|
Aug 17 - Aug 19
| ||
Form 4
| +21.29% | 11K |
$18.00 | $198,000.00 | 62.66K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
∞
| 51.66K |
$11.00 |
—
| 51.66K |
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ANAPTYSBIO INC (ANAB) Snapshot price: $35.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
∞
| 64.3K |
—
|
—
| 64.3K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Certara, Inc. (CERT) Snapshot price: $11.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.06K |
—
|
—
| 7.06K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Frazier Lifesciences Acquisition Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |